Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. - Wikidata - thesis-toulmin - TriplyDB

Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis.

Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis.

http://www.wikidata.org/entity/Q34390999

about

Immune Homeostasis in Epithelial Cells: Evidence and Role of Inflammasome Signaling Reviewed Emerging role of HMGB1 in fibrotic diseases Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study 2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation.HMGB1 in health and disease.IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients.Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.Novel outcome measures for clinical trials in cystic fibrosis 2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity.Biomarkers for cystic fibrosis drug development.Bile acids repress hypoxia-inducible factor 1 signaling and modulate the airway immune response.Treatment with rhDNase in patients with cystic fibrosis alters in-vitro CHIT-1 activity of isolated leucocytes.The TAK1→IKKβ→TPL2→MKK1/MKK2 Signaling Cascade Regulates IL-33 Expression in Cystic Fibrosis Airway Epithelial Cells Following Infection by Pseudomonas aeruginosa.Strategies for the etiological therapy of cystic fibrosis.Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis.Neutrophil elastase increases airway ceramide levels via upregulation of serine palmitoyltransferase.Sleep Phase Delay in Cystic Fibrosis: A Potential New Manifestation of Cystic Fibrosis Transmembrane Regulator Dysfunction.High-Mobility Group Box 1 Upregulates MUC5AC and MUC5B Expression in Primary Airway Epithelial Cells.Microbial Interactions in the Cystic Fibrosis Airway High HMGB1 levels in sputum are related to pneumococcal bacteraemia but not to disease severity in community-acquired pneumonia

P2860

Q26781987-AC8DFBB9-5330-46D2-A0AD-CA63069B12CF Q26828596-F457566B-25BE-4DEA-8B0D-6848C5764635 Q28387701-7A762A9F-5F17-4E55-AF00-976509C6EB42 Q28551208-3FF9BEBC-B218-43D1-BF78-8FE13E28CB6B Q33799602-42369306-6C8F-4434-9D7E-09A7B6998749 Q34622835-686CF36C-11BD-4777-98B5-F1F83F209E46 Q34973839-7D7202F7-4C94-4984-96F3-7724D2089792 Q35095433-12B3FF00-C284-4542-B3DD-BE35B34988F0 Q37700876-119DCDA7-895F-425A-BFA3-C1B9A7C5C81A Q38340406-B7AA553B-9C38-40AD-A7ED-666354A295D6 Q38748673-5866F189-1FA4-4936-91D6-BDBB4B84F14F Q38755600-938558B5-F87E-4393-B443-BC1D5BF21AD3 Q38986276-9E3447DB-0760-4227-A8B9-D745FC12C86F Q39669137-096DAA2C-DE7A-43A5-B7B8-209D0B0B27B4 Q40823404-56390AFF-932E-4A64-905F-C66D739291FE Q42650380-F924AAA0-0BBE-49F2-BB93-2DA37EFE3D92 Q43144153-396D1360-5AAB-4708-B747-D9F7E8F8FA8E Q45069913-4ED84365-6622-40F9-A4A3-AE1BE06130AD Q47738352-B013AC4E-BC8C-440C-B75F-F431D2F9F2B9 Q48331221-39E3ACCA-B360-4773-980C-AFF4ADD39350 Q57174565-D68A602F-A04C-4A56-9534-DFCD7BB343C4 Q58759782-676B64C8-D4E2-4C76-B81D-7492492DA217

P2860

Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis.

http://www.wikidata.org/entity/Q34390999

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@ast

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@en

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@nl

type

label

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@ast

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@en

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@nl

prefLabel

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@ast

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@en

Sputum biomarkers and the pred ...... patients with cystic fibrosis.

@nl

P1433

Q34390999-9B4A7A29-9E49-49BC-B0FD-5AA344B21873

P1476

Q34390999-1AF3D752-B145-4225-B457-A8CF5259DC0D

P2093

Q34390999-214AAF9B-2EB4-494D-8AD3-A1A9C53FA49F

Q34390999-317EC23A-CCD4-4116-96B7-7C424B4795C7

Q34390999-4154B311-27A5-4926-B530-EF3AE4C9C851

Q34390999-4AEFF26D-2F67-4BDC-A778-F6E3D0954F21

Q34390999-4E8CB52C-E6E4-41CB-8799-19967112FF91

Q34390999-557C8948-3997-478B-87C4-7DB21E77A28E

Q34390999-672EE2EE-6199-43CB-BA2F-FED6B877A8E8

Q34390999-80A1A0AD-980E-44AF-8093-E7DA4D5B6A69

Q34390999-939E5E1F-AFCF-44EA-B16D-AA2ED065E1EA

Q34390999-95E84D00-4CEC-4055-A824-7CAD6ABA2B4E

P2860

Q34390999-03D1D3C9-1CA5-4F98-9F3D-BD361844A2DC

Q34390999-093EA55A-14CE-4837-AA75-3FDAEEFDF535

Q34390999-0C78A67E-3DE8-4253-AEBE-88D55E4E026E

Q34390999-0D17C99D-9FC0-43BC-9FC3-AC785E24E560

Q34390999-1916B63D-8731-4885-9F2F-52E5AC485709

Q34390999-1C10358A-51A8-487F-BD35-F46A80AB2CBD

Q34390999-1CD8AF5A-2B8A-485E-9B84-5C484AB97962

Q34390999-2A9A8EB5-D52B-46ED-949F-C507ACE865FE

Q34390999-51C3C091-EF46-4E1D-BBA6-4F4C7209AE38

Q34390999-54BE3EDB-4E94-4C0F-8659-E53D414DAFB4

P304

Q34390999-82089528-4D23-4E3A-A663-D115EF9251A2

P31

Q34390999-64DCA2F7-73BE-4734-BB95-98D1A52FC361

P356

Q34390999-08A138D4-7CC1-495F-A6FA-6E59B90793FF

P407

Q34390999-89881ABE-4A94-4224-AE7A-7A81328E05A5

P433

Q34390999-BD8A8CCE-89C3-474E-B9D4-16AEF041DF6B

P478

Q34390999-453E8A0B-E9B6-4CBD-8847-4BC40821396D

P50

Q34390999-1B5E232E-287A-405F-B622-245ADFD12F56

P577

Q34390999-E362E5C8-371B-4FD1-8F54-F6F4E641035A

P5875

Q34390999-5DB381C0-6D63-46DC-8865-D2B4EE038A19

P698

Q34390999-E9D37FA0-E9F5-4F6C-B210-60E98E2AC591

P921

Q34390999-5BA5B2D8-A97F-42A2-9818-F6BC58574FBF

Q34390999-7FBD7208-6F22-47FF-B1F2-FE29CB31FC30

Q34390999-9A99093F-55EC-45A3-9F59-F86A2B6F1A0A

P932

Q34390999-BC7CC7DF-2D90-4045-B90D-3F24847199C8

P356

JOURNAL.PONE.0042748

P1433

P1476

Sputum biomarkers and the pred ...... patients with cystic fibrosis

@en

P2093

Anne Sturrock

http://www.w3.org/2001/XMLSchema#string

Christen Lane

http://www.w3.org/2001/XMLSchema#string

David R Cox

http://www.w3.org/2001/XMLSchema#string

Frederick R Adler

http://www.w3.org/2001/XMLSchema#string

Holly Carveth

http://www.w3.org/2001/XMLSchema#string

James Moore

http://www.w3.org/2001/XMLSchema#string

John R Hoidal

http://www.w3.org/2001/XMLSchema#string

Judy L Jensen

http://www.w3.org/2001/XMLSchema#string

Jun Chen

http://www.w3.org/2001/XMLSchema#string

Kristyn Packer

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis

High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

HMG-1 as a late mediator of endotoxin lethality in mice

Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties

Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters

Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages

Predictive 5-year survivorship model of cystic fibrosis.

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

P304

e42748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0042748

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Theodore G. Liou

P577

2012-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230724281

http://www.w3.org/2001/XMLSchema#string

P698

22916155

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

3416785

http://www.w3.org/2001/XMLSchema#string